Moderna Covid-19 vaccine granted regulatory authorisation in UK
The UK regulatory agency MHRA authorised the vaccine based on a rolling review of data, including data from…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
11 Jan 21
The UK regulatory agency MHRA authorised the vaccine based on a rolling review of data, including data from…
11 Jan 21
Lenzilumab is an anti-human GM-CSF monoclonal antibody, designed to prevent and treat cytokine storm in Covid-19 patients
08 Jan 21
The acquisition of AmpTec will allow Merck to strengthen its capabilities in developing and manufacturing mRNA, used in…
08 Jan 21
Commonwealth of Australia signed an advance purchase agreement with Novavax for its adjuvanted protein vaccine candidate NVX-CoV2373
07 Jan 21
The new manufacturing site for biopharmaceuticals will offer an end-to-end single-site solution from drug substances to fill-finish and…
07 Jan 21
EC authorisation follows European Medicines Agency recommendation and CHMP positive opinion for Moderna’s Covid-19 Vaccine
06 Jan 21
The US FDA’s break through designation is based on data from the Phase 2 CITYSCAPE trial of tiragolumab…
05 Jan 21
Israel’s Ministry of Health has secured six million doses of the Moderna Covid-19 vaccine, with initial supply expected…
05 Jan 21
The new facility, to be located in Watertown, Massachusetts, will manufacture viral vectors and advanced therapies
04 Jan 21
Bharat Biotech's Covaxin has been approved for restricted use in emergency situation in public interest as an abundant…